Fol. Biol. 2008, 54, 102-108
https://doi.org/10.14712/fb2008054030102
Lack of Association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 Polymorphisms for Susceptibility and Outcome in Brazilian Prostate Cancer Patients
References
1. 2006) Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 66, 146-156.
< , I., Langeberg, W. J., Lampe, J. W., Salinas, C. A., Stanford, J. L. (https://doi.org/10.1002/pros.20305>
2. 2004) CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet. Cytogenet. 154, 81-85.
< , D., Hascicek, M., Sozen, S., Ozen, H., Tuncbilek, E. (https://doi.org/10.1016/j.cancergencyto.2004.01.023>
3. 1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 272, 10004-10012.
< , F., Akande, O., Antoun, G., Mao, J. X., Buolamwini, J. (https://doi.org/10.1074/jbc.272.15.10004>
4. 2000) Identification, characterization, and crystal structure of the Omega class glutathione transferases. J. Biol. Chem. 275, 24798-24806.
< , P. G., Coggan, M., Chelvanayagam, G., Easteal, S., Jermiin, L. S., Schulte, G. K., Danley, D. E., Hoth, L. R., Griffor, M. C., Kamath, A. V., Rosner, M. H., Chrunyk, B. A., Perregaux, D. E., Gabel, C. A., Geoghegan, K. F., Pandit. J. (https://doi.org/10.1074/jbc.M001706200>
5. 2006) Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocr. Relat. Cancer 13, 1185-1193.
< , N. E., Leite, J. L., Guilhen, A. C., Morari, E. C., Granja, F., Assumpcao, L. V., Ward, L. S. (https://doi.org/10.1677/ERC-06-0002>
6. 2003) Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int. J. Cancer 106, 375-378.
< , B. L., Zheng, S. L., Isaacs, S. D., Turner, A., Hawkins, G. A., Wiley, K. E., Beecker, E. R., Walsh, P. C., Meyers, D. A., Isaacs, W. B., Xu, J. (https://doi.org/10.1002/ijc.11249>
7. 2001) The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. 276, 3319-3323.
< , A., Gage, P., Curtis, S., Chelvanayagam, G., Board, P. (https://doi.org/10.1074/jbc.M007874200>
8. 2007) Prostate cancer prevention: past, present, and future. Cancer 110, 1889-1899.
< , N., Zlotta A. R. (https://doi.org/10.1002/cncr.23009>
9. 2005) GSTO polymorphism analysis in thyroid nodules suggests that GSTO1 variants do not influence the risk for malignancy. Eur. J. Cancer Prev. 14, 277-280.
< , F., Morari, E. C., Assumpcao, L. V. M., Ward, L. S. (https://doi.org/10.1097/00008469-200506000-00013>
10. 1995) Conjugation of carcinogens by class glutathione s-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics 5, 103-107.
< , F. P, Their, R., Persmark, M., Taylor, J. B., Pemble, S. E., Ketterer, B. (https://doi.org/10.1097/00008571-199512001-00010>
11. Instituto Nacional do Cancer (INCA) 2007. http://www.inca.gov.br/estimativa/2007. Cited 20. Dec. 2007.
12. 2004) CYP3A4 polymorphisms – potential risk factors for breast and prostate cancer: a HuGE review. Am. J. Epidemiol. 160, 825-841.
< , C, McCanlies, E. C., Weston A. (https://doi.org/10.1093/aje/kwh294>
13. 2004) Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 58, 1056-1062.
< , G, S., Butler, W. M., Wallner, K. E., Galbreath, R. W., Lief, J. H., Adamovich, E. (https://doi.org/10.1016/j.ijrobp.2003.08.021>
14. 2002) The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol. Biomarkers Prev. 11, 1485-1488.
, E. C., Leite, J. L. P., Granja, F., Assumpcao, L. V. M., Ward, L. S. (
15. 2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 165, 171-177.
< , M., Watanabe, M., Yamanaka, M., Kubota, Y., Ito, H., Nagao, M., Katoh, T., Kamataki, T., Kawamura, J., Yatani, R., Shiraishi, T. (https://doi.org/10.1016/S0304-3835(01)00398-6>
16. 2005) Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 14, 176-181.
< , C., Polycarpou, A., Ioannidis, J. P. (https://doi.org/10.1158/1055-9965.176.14.1>
17. 2002) Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Neoplasma 49, 209-216.
, E., Wasowicz, W. (
18. 1998) Hereditary differences in the expression of the human glutathione transferase activity on trans-stilbene oxide are due to gene deletion. Proc. Natl. Acad. Sci. USA 85, 7293-7297.
< , J., Vorachek, W. R, Pero, R. W, Pearson, W. R. (https://doi.org/10.1073/pnas.85.19.7293>
19. 2003) Efficiency of 6-and 12-punctures biopsies to detect prostate cancer in patients with PSA Int. Braz. J. Urol. 29, 24-30.
< , L. E., Sugisawa, M. C., Ioshii, S. O., Filho, R. T., Rocha, L. C. (https://doi.org/10.1590/S1677-55382003000100005>
20. 2003) Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochem. Biophys. Res. Commun. 301, 516-520.
< , T., Jinno, H., Hasegawa, T., Makino, Y., Seko, Y., Hanioka, N, Ando, M. (https://doi.org/10.1016/S0006-291X(02)03066-8>
21. 2000) Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21, 1683-1689.
< , J. A., Martin, F. L., Muir, G. H., Hewer, A., Grover, P. L., Phillips, D. H. (https://doi.org/10.1093/carcin/21.9.1683>